Correction to: Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro

Minhua Rong,Gang Chen,Yiwu Dang

DOI: https://doi.org/10.1186/s12885-020-6680-3

IF: 4.638

2020-01-01

BMC Cancer

Abstract:Following publication of the original article [1], the authors reported that they had misspelt the name of a cell line and supplied the incorrect Fig. 7 for publication.

What problem does this paper attempt to address?

Correction: Chao Et Al. MicroRNA-22-3p and MicroRNA-149-5p Inhibit Human Hepatocellular Carcinoma Cell Growth and Metastasis Properties by Regulating Methylenetetrahydrofolate Reductase. Curr. Issues Mol. Biol. 2022, 44, 952–962

Chao Li,Xiang Li,Han Wang,Xihan Guo,Jinglun Xue,Xu Wang,Juan Ni

DOI: https://doi.org/10.3390/cimb46090630

2024-01-01

Current Issues in Molecular Biology

Abstract:Author Correction: We apologize for unintentionally using the wrong figures (Figure 5b and Figure 6e) in the original article [...]
Correction To: MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Jing Zheng,Tao Xu,Feng Chen,Ying Zhang

DOI: https://doi.org/10.1007/s12253-020-00794-3

2020-01-01

Abstract:The original version of this article unfortunately contained an error in the affiliation section.
Erratum: MiR-30a-5p Suppresses Cell Growth and Enhances Apoptosis of Hepatocellular Carcinoma Cells Via Targeting AEG-1.

Rui-Wen He,Lu Yang,Xiao Lin,Xuesong Chen,Fuxiang Wei,Xin Liang,Yunping Luo,Yi Wu,Gan T,Yi‐Wu Dang,G Chen

2020-01-01

Abstract:[This corrects the article on p. 15632 in vol. 8, PMID: 26884832.].
Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma

Shuang Wei,Zun-yi Zhang,Sheng-ling Fu,Jun-gang Xie,Xian-sheng Liu,Yong-jian Xu,Jian-ping Zhao,Wei-ning Xiong

DOI: https://doi.org/10.1038/s41419-018-0880-7

2018-01-01

Abstract:Following publication of their article, the authors noticed that there were minor errors in Figs. 3, 7 and S5. The errors had no effect on the scientific content or conclusions. The rectified figures are given below.
Author Correction: PBX3 is Targeted by Multiple Mirnas and is Essential for Liver Tumour-Initiating Cells

Han, Haibo,Du, Yantao,Zhao, Wei,Li, Sheng,Chen, Dongji,Zhang, Jing,Liu, Jiang,Suo, Zhenhe,Bian, Xiuwu,Xing, Baocai,Zhang, Zhiqian

DOI: https://doi.org/10.1038/s41467-019-10052-z

IF: 16.6

2019-01-01

Nature Communications

Abstract:This Article contains an error in Figure 3. In panel g, images representing miR-222-TuD and miR-424-TuD were both taken from the miR-222-TuD image. The correct version of Figure 3 is shown in the accompanying Author Correction.
[Corrigendum] Propofol‐induced HOXA11‐AS promotes proliferation, migration and invasion, but inhibits apoptosis in hepatocellular carcinoma cells by targeting miR‐4458

Furong Song,Jun Liu,Yawei Feng,Yi Jin

DOI: https://doi.org/10.3892/ijmm.2024.5351

IF: 5.314

2024-01-22

International Journal of Molecular Medicine

Abstract:Following the publication of the above article, an interested reader drew to the authors' attention that the western blots for the PCNA and cyclin D1 bands appeared to be strikingly similar. The authors were able to re‑examine their original data, and recognize how the error was made with respect to the compilation of this figure (they were also able to demonstrate to the Editorial Office how the error occurred). The revised version of Fig. 3, now incorporating the correct data for the PCNA bands in Fig. 3A, is shown on the next page. The authors can confirm that the errors associated with this figure did not have a significant impact on either the results or the conclusions reported in this study, and all the authors agree with the publication of this Corrigendum. The authors are grateful to the Editor of <i>International Journal of Molecular Medicine</i> for allowing them the opportunity to publish this Corrigendum; furthermore, they apologize to the readership of the Journal for any inconvenience caused. [International Journal of Molecular Medicine 46: 1135‑1145, 2020; DOI: 10.3892/ijmm.2020.4667].

medicine, research & experimental
[Corrigendum] MicroRNA‑92a Contributes to Tumor Growth of Human Hepatocellular Carcinoma by Targeting FBXW7

Wei Yang,Changwei Dou,Yufeng Wang,Yuli Jia,Chao Li,Xin Zheng,Kangsheng Tu

DOI: https://doi.org/10.3892/or.2023.8596

2023-01-01

Oncology Reports

Abstract:Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that certain of the control western blotting data featured in Fig. 5 on p. 2581 had also appeared in a couple of other articles featuring several of the same authors [Tu K, Dou C, Zheng X, Li C, Yang W, Yao Y and Liu Q: Fibulin‑5 inhibits hepatocellular carcinoma cell migration and invasion by down‑regulating matrix metalloproteinase‑7 expression. BMC Cancer 14: 938, 2014; and Gai X, Tu K, Li C, Roberts LR and Zheng X: Histone acetyltransferase PCAF accelerates apoptosis by repressing a GLI1/BCL2/BAX axis in hepatocellular carcinoma. Cell Death Dis 6: e1712, 2015]. In addition, the authors drew to the attention of the Editorial Office that a couple of mistakes were made during the assembly of Fig. 2D on p. 2579. The authors were able to re-examine their original data files, and realized that these figures had been inadvertently assembled incorrectly (they were also able to present the raw data from which these figures had been assembled to the Editorial Office). The revised versions of Figs. 2 and 5, containing the intended flow cytometric and western blotting data for these figures respectively, is shown on the next page. The authors wish to emphasize that the corrections made to these figures do not affect the overall conclusions reported in the paper, and they are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this corrigendum. All the authors agree to the publication of this corrigendum, and also apologize to the readership for any inconvenience caused. [Oncology Reports 34: 2576‑2584, 2015; DOI: 10.3892/or.2015.4210].
[Corrigendum] MicroRNA‑222‑3p promotes tumor cell migration and invasion and inhibits apoptosis, and is correlated with an unfavorable prognosis of patients with renal cell carcinoma

Liwen Zhao,Jing Quan,Zuwei Li,Xiang Pan,Jingyao Wang,Jinling Xu,Weijie Xu,Xin Guan,Hang Li,Shangqi Yang,Yaoting Gui,Yun Chen,Yongqing Lai

DOI: https://doi.org/10.3892/ijmm.2024.5377

Abstract:Following the publication of the above article, an interested reader drew to the attention of the Editorial Office that, in Fig. 3A on p. 530, two pairs of data panels were overlapping, such that certain of the panels appeared to have been derived from the same original sources where the results from differently performed experiments were intended to have been portrayed. The authors have examined their original data, and realize that errors associated with data handling/labelling during the preparation of the representative images in Fig. 3A had occurred. The revised version of Fig. 3, showing the correct data for the 'NC/ACHN/Invasion and Migration' data panels, the 'Inhibitor NC/786‑O' panel and the 'Inhibitor NC/ACHN/Invasion' panel, is shown on the next page. The authors can confirm that the errors associated with this figure did not have any significant impact on either the results or the conclusions reported in this study, and all the authors agree with the publication of this Corrigendum. The authors are grateful to the Editor of International Journal of Molecular Medicine for giving them the opportunity to publish this Corrigendum; furthermore, they apologize to the readership of the Journal for any inconvenience caused. [International Journal of Molecular Medicine 43: 525‑534, 2019; DOI: 10.3892/ijmm.2018.3931].
[Corrigendum] Effects of miR‑340 overexpression and knockdown on the proliferation and metastasis of NSCLC cell lines

Xidan Zhu,Gang Tian,Jing Quan,Peng He,Jinbo Liu

DOI: https://doi.org/10.3892/ijmm.2024.5433

Abstract:Following the publication of the above article, an interested reader drew to the authors' attention that, with the 'Adjacent' row (top row) of immunohistochemical images shown in Fig. 2 on p. 646, the fourth and fifth panels along (the 'RAB11A' and 'RAB9A' data panels) contained an overlapping section of data, such that data which were intended to show the results from differently performed experiments had apparently been derived from the same original source. After consulting their original data, the authors were able to determine that the duplication of these panels had inadvertently occurred during the process of compiling Fig. 2. The revised version of Fig. 2, featuring the correct data for the 'Adjacent/RAB9A' experiment, is shown below. The authors confirm that the error associated with this figure did not have any significant impact on either the results or the conclusions reported in this study, and are grateful to the Editor of International Journal of Molecular Medicine for allowing them the opportunity to publish this Corrigendum. Furthermore, they apologize to the readership of the Journal for any inconvenience caused. [International Journal of Molecular Medicine 44: 643‑651, 2019; DOI: 10.3892/ijmm.2019.4213].
Correction: Cui, H., et al. BA-12 Inhibits Angiogenesis via Glutathione Metabolism Activation. Int. J. Mol. Sci. 2019, 20, 4062

Herong Cui,Wenbo Guo,Beibei Zhang,Guoping Li,Tong Li,Yanyan Yuan,Na Zhang,Yuwei Yang,Wuwen Feng,Fuhao Chu,Shenglan Wang,Bing Xu,Penglong Wang,Haimin Lei

DOI: https://doi.org/10.3390/ijms21186814

IF: 5.6

2020-09-17

International Journal of Molecular Sciences

Abstract:The authors wish to make the following corrections to this paper [...]

biochemistry & molecular biology,chemistry, multidisciplinary
Correction To: Minichromosome Maintenance 3 Promotes Hepatocellular Carcinoma Radioresistance by Activating the NF-κB Pathway.

Qing Yang,Binhui Xie,Hui Tang,Wei Meng,Changchang Jia,Xiaomei Zhang,Yi Zhang,Jianwen Zhang,Heping Li,Binsheng Fu

DOI: https://doi.org/10.1186/s13046-019-1338-1

2019-01-01

Abstract:In the original publication of this article [1], the authors reported the order of the authors was incorrect and needs to be revised. The original article has been updated to rectify this error.
[Corrigendum] microRNA‐181a‐5p functions as an oncogene in renal cell carcinoma

Yulin Lai,Liwen Zhao,Jia Hu,Jing Quan,Peijie Chen,Jinling Xu,Xin Guan,Yongqing Lai,Liangchao Ni

DOI: https://doi.org/10.3892/mmr.2024.13182

IF: 3.423

2024-02-16

Molecular Medicine Reports

Abstract:Following the publication of the above article and a corrigendum in 2018 that corrected details of the correspondence information for authors, errors made in Fig. 5 and the funding details (doi: 10.3892/mmr.2018.9117), an interested reader drew to the authors' attention that, in Fig. 6 on p. 8515 showing the results of cell migration and invasion assay experiments, a pair of data panels were overlapping, such that data which were intended to show the results from differently performed experiments appeared to have been derived from the same original source. After having consulted their original data, the authors have realized that Fig. 6 was assembled incorrectly, The revised version of Fig. 6, now showing the correct data for the 'ACHN/migratory/NC' experiment, is shown on the next page. Note that all the authors approve of the publication of this corrigendum, and the authors are grateful to the Editor of Molecular Medicine Reports for granting them the opportunity to publish this. The authors regret their oversight in allowing this error to be included in the paper, and also apologize to the readership for any inconvenience caused. [Molecular Medicine Reports 17: 8510‐8517, 2018; DOI: 10.3892/mmr.2018.8899]

oncology,medicine, research & experimental
Correction To: MiR-139-5p Inhibits Migration and Invasion of Colorectal Cancer by Downregulating AMFR and NOTCH1

Mingxu Song,Yuan Yin,Jiwei Zhang,Binbin Zhang,Zehua Bian,Chao Quan,Leyuan Zhou,Yaling Hu,Qifeng Wang,Shujuan Ni,Bojian Fei,Weili Wang,Xiang Du,Hua Dong,Zhaohui Huang

DOI: https://doi.org/10.1007/s13238-021-00826-x

2021-01-01

Protein & Cell

Abstract:In the original publication the display of Fig. 1 is incorrect. The correct figure is available in this correction.
Correction: MiR-HCC2 Up-regulates BAMBI and ELMO1 Expression to Facilitate the Proliferation and EMT of Hepatocellular Carcinoma Cells

Jianying Yi,Yajie Fan,Le Zhang,Hong Wang,Ting Mu,Hong Xie,Huijie Gao,Min Liu,Shengping Li,Hua Tang

DOI: https://doi.org/10.7150/jca.66366

IF: 3.9

2021-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.30858.].

oncology
Author Correction: A Novel Microrna Signature Predicts Survival in Liver Hepatocellular Carcinoma after Hepatectomy

Qiang Fu,Fan Yang,Tengxiao Xiang,Guoli Huai,Xingxing Yang,Liang Wei,Hongji Yang,Shaoping Deng

DOI: https://doi.org/10.1038/s41598-018-27641-5

IF: 4.6

2018-01-01

Scientific Reports

Abstract:A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.
Correction To: M6a Mrna Methylation Regulates CTNNB1 to Promote the Proliferation of Hepatoblastoma

Li Liu,Jing Wang,Guifeng Sun,Qiong Wu,Ji Ma,Xin Zhang,Nan Huang,Zhixuan Bian,Song Gu,Min Xu,Minzhi Yin,Fenyong Sun,Qiuhui Pan

DOI: https://doi.org/10.1186/s12943-020-1136-6

IF: 37.3

2020-01-01

Molecular Cancer

Abstract:fter the publication of this work [1], the authors noticed that the affiliations were incorrectly provided. Updated affiliation section is provided in this paper.
Corrigendum to "Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients"

Lei Qian,Nanya Wang,Huimin Tian,Haofan Jin,Hengjun Zhao,Chao Niu,Hua He,Tingwen Ge,Wei Han,Jifan Hu,Dan Li,Fujun Han,Jianting Xu,Xiao Ding,Jingtao Chen,Wei Li,Jiuwei Cui

DOI: https://doi.org/10.1155/2022/9761463

IF: 4.4929

2022-07-18

Journal of Immunology Research

Abstract:In the article titled "Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients" [1], the authors wish to correct Figure 2. Due to an oversight when preparing the manuscript, it is duplicated with Figure 3 in a previous publication by the authors [2]. These two studies were related, and the data were saved to the same location, contributing to the erroneous selection of the image for publication. The authors apologise for this error and provide the corrected Figure 2 as follows:

immunology
Erratum: [Corrigendum] miR‑216a‑5p acts as an oncogene in renal cell carcinoma.

Peijie Chen,Jing Quan,Lu Jin,Canbin Lin,Weijie Xu,Jinling Xu,Xin Guan,Zebo Chen,Liangchao Ni,Shangqi Yang,Yun Chen,Yongqing Lai

DOI: https://doi.org/10.3892/etm.2024.12443

IF: 2.7

2024-01-01

Experimental and Therapeutic Medicine

Abstract:[This corrects the article DOI: 10.3892/etm.2018.5881.].
[Corrigendum] MicroRNA‑218 Inhibits Tumor Angiogenesis of Human Renal Cell Carcinoma by Targeting GAB2

Lijun Mu,Bing Guan,Jie Tian,Xiang Li,Qi Long,Meiyu Wang,Wen Wang,Junjun She,Xudong Li,Dapeng Wu,Yifan Du

DOI: https://doi.org/10.3892/or.2022.8406

2022-01-01

Oncology Reports

Abstract:Subsequently to the publication of the above article, the authors have realized that the cell migration and tube formation assay data portrayed in Figs. 2 and 4 in their paper were published with some inadvertent errors. Specifically, the photograph selected for the ACHN-SFM group was accidentally misused for the 769P/LV-miR-218 group in Fig. 2F. Secondly, the photograph for the 786O/LV‑NC group in Fig. 2F was accidentally misused as the image for the 786O/shNC group in Fig. 4E; and thirdly, the photograph selected for the ACHN/shNC group in Fig. 4C was inadvertently misused for the ACHN/shNC group in Fig. 4D. These errors arose inadvertently as a consequence of the authors' mishandling their data; however, the authors were able to retrieve their original data, and have been able to reassemble these figures to show the data as was originally intended. The revised versions of Figs. 2 and 4, featuring the corrected data panels for the 769P/LV‑miR‑218 group in Fig. 2F, the ACHN/shNC group in Fig. 4D and the 786O/shNC group in Fig. 4E, are shown on the next two pages. The revised data shown for these Figures do not affect the overall conclusions reported in the paper. All the authors agree with the publication of this corrigendum. The authors are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this corrigendum, and apologize to the readership for any inconvenience caused. [Oncology Reports 44: 1961‑1970, 2020; DOI: 10.3892/or.2020.7759].
Correction to: miR-195-5p/NOTCH2-mediated EMT modulates IL-4 secretion in colorectal cancer to affect M2-like TAM polarization

Xiaobin Lin,Shuyi Wang,Min Sun,Chunxiao Zhang,Chen Wei,Chaogang Yang,Rongzhang Dou,Qing Liu,Bin Xiong

DOI: https://doi.org/10.1186/s13045-019-0810-x

IF: 28.5

2019-01-01

Journal of Hematology & Oncology

Abstract:In the original article [1], the terms ‘osISET’ and ‘ISET’ within the ‘CTC capture’ sub-section of the Materials and Methods section have both been replaced with ‘CTCBIOPSY®’.

Correction to: Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro

Correction: Chao Et Al. MicroRNA-22-3p and MicroRNA-149-5p Inhibit Human Hepatocellular Carcinoma Cell Growth and Metastasis Properties by Regulating Methylenetetrahydrofolate Reductase. Curr. Issues Mol. Biol. 2022, 44, 952–962

Correction To: MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Erratum: MiR-30a-5p Suppresses Cell Growth and Enhances Apoptosis of Hepatocellular Carcinoma Cells Via Targeting AEG-1.

Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma

Author Correction: PBX3 is Targeted by Multiple Mirnas and is Essential for Liver Tumour-Initiating Cells

[Corrigendum] Propofol‐induced HOXA11‐AS promotes proliferation, migration and invasion, but inhibits apoptosis in hepatocellular carcinoma cells by targeting miR‐4458

[Corrigendum] MicroRNA‑92a Contributes to Tumor Growth of Human Hepatocellular Carcinoma by Targeting FBXW7

[Corrigendum] MicroRNA‑222‑3p promotes tumor cell migration and invasion and inhibits apoptosis, and is correlated with an unfavorable prognosis of patients with renal cell carcinoma

[Corrigendum] Effects of miR‑340 overexpression and knockdown on the proliferation and metastasis of NSCLC cell lines

Correction: Cui, H., et al. BA-12 Inhibits Angiogenesis via Glutathione Metabolism Activation. Int. J. Mol. Sci. 2019, 20, 4062

Correction To: Minichromosome Maintenance 3 Promotes Hepatocellular Carcinoma Radioresistance by Activating the NF-κB Pathway.

[Corrigendum] microRNA‐181a‐5p functions as an oncogene in renal cell carcinoma

Correction To: MiR-139-5p Inhibits Migration and Invasion of Colorectal Cancer by Downregulating AMFR and NOTCH1

Correction: MiR-HCC2 Up-regulates BAMBI and ELMO1 Expression to Facilitate the Proliferation and EMT of Hepatocellular Carcinoma Cells

Author Correction: A Novel Microrna Signature Predicts Survival in Liver Hepatocellular Carcinoma after Hepatectomy

Correction To: M6a Mrna Methylation Regulates CTNNB1 to Promote the Proliferation of Hepatoblastoma

Corrigendum to "Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients"

Erratum: [Corrigendum] miR‑216a‑5p acts as an oncogene in renal cell carcinoma.

[Corrigendum] MicroRNA‑218 Inhibits Tumor Angiogenesis of Human Renal Cell Carcinoma by Targeting GAB2

Correction to: miR-195-5p/NOTCH2-mediated EMT modulates IL-4 secretion in colorectal cancer to affect M2-like TAM polarization